Women's Health and the Healthcare Pharmaceutical Industry

Women are Increasingly Attractive to Pharma

“Companies are missing out, not just on female specific disorders,” warns Williams, “but missing out in general, because there is usually a women’s health angle that companies are not picking up on. There’s evidence coming out of female specific aspects in cardiovascular disease and diabetes, for example.”

While it continues to test Viagra in women, Pfizer has taken a slightly different approach. It may not yet have much in the way of treatments for gynecological conditions, but it is already marketing to the female population. Pfizer’s website homepage has a link to a specific site for women that presents the company’s entire range of products with women in mind.

“This is a hint of where things are going,” says Jenny Coe. “Women are looking for information more than men, and Pfizer is tapping into this. As far as the women are concerned, they don’t have to know the products are all the same.”

The web offers an obvious channel for pharmaceutical companies to communicate directly with female patients. But they also need to find ways to exploit the well developed patient-physician relationship too. This may come through offering a range of patient support services that doctors and women will both find useful.

Perhaps the largest major obstacle the drug firms will confront is question of size. The most effective franchise must provide a full range of products and services under a single brand. This is too much even for the industry giants, but Jenny Coe suggests a way forward. “Companies need to adapt to thechanging environment. They need to become a one-stop shop for women’s health. They don’t have to necessarily produce everything in house, but be the provider and the brand. There could be a virtual network (through distribution and licensing agreements) of companies expert in their own fields. As far as the woman is concerned they only need to know one company -- the franchise brand. This is to women’s health management -- looking after the person and all her needs.”

“I can’t point to anyone doing this at the moment,” says Coe, “but in the long term it will happen. This is definitely something new that pharma companies will have to tackle.” Those companies that already have a reputation in women’s health perhaps have the head start, but with so many competitors entering into the market, it is more a question of who takes the franchise initiative first.

By Edwin Colyer

Page 1 2 3 4
Return to Top

Par Excellence is the respected voice amidst the chatter of other women's magazine titles. In Par Excellence top female executives share information on all the topics that their counterparts crave, including networking, executive coaching, mentoring, financial planning and financial strategies for women, fashion, technology, marketing trends, family, healthy lifestyle, success strategies, diversity & inclusion and much, much more.